Mastek Ltd Q1 FY27 Earnings Analysis

- FY27 is expected to be a positive growth year, outperforming FY26 with stronger order backlog execution. - North America business shows positive sequential order book growth and is anticipated to stabilize and grow. - AMEA business is turning around with a reset focus on healthcare, BFSI, and manufacturing, expected to grow in FY27 despite geopolitical uncertainties. - U.K. business continues to perform well, with growth in new government departments and private sector healthcare and financial services. - The shift from project-based to fixed bid/outcome-based contracts is expected to support stable long-term revenues. - AI-led business verticals are growing; AI order book increased from 3% to 9%, with scalability expected as AI use cases become enterprise-wide. - Overall, cautious optimism due to volatile macroeconomic and AI-driven market conditions, but growth momentum is positive.

- FY27 is expected to be a positive growth year with better performance than FY26, supported by a stronger 12-month order backlog and improving lead indicators. - Revenue growth outlook: Growth is anticipated but with caution due to volatile macro environment and AI-led pricing pressures; no specific numeric guidance given. - Margins: Stable margin performance around 16%-16.1% EBITDA expected for FY27, balancing operational efficiency gains, AI investments, and pricing pressures. - Earnings: PAT grew 7.5% Y-o-Y in FY26, with EPS up by 7.1% (basic) and 7.3% (diluted); similar positive trajectory expected, though no explicit future EPS guidance given. - AI-led transformation and shift to outcome-based fixed bid contracts are expected to drive future efficiency and profitability improvements. - Headcount growth expected to be slower than revenue growth, improving revenue per employee and margins over time.

- Mastek is actively considering M&A as part of its capital allocation strategy, focusing on acquisitions that enhance vertical and domain-specific capabilities, especially in core business areas rather than peripheral digital activities. - The company is also looking at smaller strategic AI investments and partnerships with significant AI players to bolster their AI capabilities. - Current focus for M&A and investments is tightly aligned with verticalization and AI-driven business transformation. - No specific large-scale capex or capital expenditure projects are mentioned; the emphasis is on inorganic growth through targeted acquisitions and ecosystem partnerships. - Cash on the books has been increasing quarter-on-quarter, facilitating these strategic investments.

The transcript does not mention any current or planned fundraising through debt or equity by Mastek Limited. Key points related to financial strategy include: - Mastek has a strong cash position, with cash and cash equivalents of INR 938 crores as of March 2026, up 51% from the previous year. - The company is actively considering M&A for strategic growth, especially to enhance AI verticals, utilizing its growing cash reserves. - There is no disclosure of any plans for debt or equity fundraising. - Focus is on utilizing internal cash for acquisitions and partnerships rather than raising capital through debt or equity markets. Hence, no new fundraising through debt or equity is indicated currently or in the near future.

- The 12-month order backlog has increased significantly, providing a much stronger foundation entering FY27. - Order book growth is positive, particularly in the U.K. business, while North America shows improvement but limited 12-month backlog growth. - The North America business has seen sequential order book growth across Q2, Q3, and Q4. - The order backlog includes: - Longer-term orders in the U.K. public sector with tenures of 3-5 years. - Project-driven orders in Salesforce and Oracle businesses with execution periods of 1 to 1.5 years. - Ramp-up of three deals announced in March (ATLAS, FCA, Biometric): - FCA deal ramping up with over 60 onsite resources; full ramp-up expected by end of Q1 FY27. - ATLAS and Biometric deals are under negotiation for expanded scope SOWs with ramp-ups expected between Q1 and Q2 FY27. - The management is cautiously positive on book-to-ship and revenue growth given market volatility and AI-led changes.